MDRX
Income statement / Annual
Last year (2022), Allscripts Healthcare Solutions, Inc.'s total revenue was $588.02 M,
an increase of 1.83% from the previous year.
In 2022, Allscripts Healthcare Solutions, Inc.'s net income was -$86.46 M.
See Allscripts Healthcare Solutions, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$588.02 M |
$577.43 M |
$1.50 B |
$1.63 B |
$1.75 B |
$1.50 B |
$1.55 B |
$1.39 B |
$1.38 B |
$1.37 B |
| Cost of Revenue |
$279.60 M
|
$319.27 M
|
$937.01 M
|
$1.06 B
|
$1.03 B
|
$864.91 M
|
$904.87 M
|
$828.97 M
|
$831.89 M
|
$838.61 M
|
| Gross Profit |
$308.42 M
|
$258.15 M
|
$565.70 M
|
$574.51 M
|
$724.54 M
|
$632.80 M
|
$645.03 M
|
$557.43 M
|
$545.98 M
|
$534.46 M
|
| Gross Profit Ratio |
0.52
|
0.45
|
0.38
|
0.35
|
0.41
|
0.42
|
0.42
|
0.4
|
0.4
|
0.39
|
| Research and Development Expenses |
$97.89 M
|
$84.77 M
|
$206.06 M
|
$254.51 M
|
$295.77 M
|
$220.22 M
|
$188.14 M
|
$184.80 M
|
$192.82 M
|
$199.80 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$169.20 M
|
$97.71 M
|
$389.94 M
|
$419.77 M
|
$450.97 M
|
$400.69 M
|
$392.87 M
|
$339.18 M
|
$358.68 M
|
$419.60 M
|
| Other Expenses |
$68.43 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$33.67 M
|
$42.71 M
|
| Operating Expenses |
$335.52 M
|
$182.48 M
|
$596.00 M
|
$674.28 M
|
$746.00 M
|
$620.32 M
|
$606.50 M
|
$523.97 M
|
$585.17 M
|
$662.06 M
|
| Cost And Expenses |
$615.12 M
|
$500.66 M
|
$1.56 B
|
$1.73 B
|
$1.77 B
|
$1.49 B
|
$1.48 B
|
$1.35 B
|
$1.42 B
|
$1.49 B
|
| Interest Income |
$4.90 M
|
$485.00 K
|
$550.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$6.35 M
|
$13.20 M
|
$34.35 M
|
$43.17 M
|
$50.91 M
|
$37.54 M
|
$29.48 M
|
$29.96 M
|
$29.30 M
|
$24.15 M
|
| Depreciation & Amortization |
$115.92 M
|
$72.78 M
|
$87.19 M
|
$250.61 M
|
$184.36 M
|
$157.33 M
|
$136.33 M
|
$161.00 M
|
$174.26 M
|
$178.80 M
|
| EBITDA |
$58.42 M |
$243.41 M |
$108.97 M |
$12.03 M |
$171.61 M |
$41.92 M |
$197.37 M |
$191.54 M |
$135.44 M |
$54.62 M |
| EBITDA Ratio |
0.1
|
0.42
|
0.07
|
0.01
|
0.1
|
0.03
|
0.13
|
0.14
|
0.1
|
0.04
|
| Operating Income Ratio |
-0.05
|
0.13
|
-0.04
|
-0.06
|
-0.05
|
0.01
|
0.04
|
0.02
|
-0.03
|
-0.09
|
| Total Other Income/Expenses Net |
-$36.75 M
|
$82.03 M
|
-$91.65 M
|
-$182.06 M
|
$32.85 M
|
-$202.52 M
|
-$36.15 M
|
-$31.33 M
|
-$28.93 M
|
-$20.75 M
|
| Income Before Tax |
-$63.85 M
|
$157.71 M
|
-$149.31 M
|
-$281.75 M
|
-$62.20 M
|
-$190.04 M
|
$31.56 M
|
$570.00 K
|
-$68.12 M
|
-$148.35 M
|
| Income Before Tax Ratio |
-0.11
|
0.27
|
-0.1
|
-0.17
|
-0.04
|
-0.13
|
0.02
|
0
|
-0.05
|
-0.11
|
| Income Tax Expense |
-$43.81 M
|
$27.85 M
|
-$16.69 M
|
-$43.34 M
|
-$18.98 M
|
-$5.51 M
|
$309.00 K
|
$2.63 M
|
-$1.66 M
|
-$44.32 M
|
| Net Income |
-$86.46 M
|
$134.44 M
|
$700.41 M
|
-$182.18 M
|
$363.74 M
|
-$196.46 M
|
-$25.65 M
|
-$2.23 M
|
-$66.45 M
|
-$104.03 M
|
| Net Income Ratio |
-0.15
|
0.23
|
0.47
|
-0.11
|
0.21
|
-0.13
|
-0.02
|
-0
|
-0.05
|
-0.08
|
| EPS |
-0.67 |
1.03 |
4.37 |
-1.1 |
2.07 |
-1.09 |
-0.14 |
-0.01 |
-0.37 |
-0.59 |
| EPS Diluted |
-0.67 |
1.01 |
4.37 |
-1.1 |
2.04 |
-1.09 |
-0.14 |
-0.01 |
-0.37 |
-0.59 |
| Weighted Average Shares Out |
$128.90 M
|
$130.14 B
|
$159.28 M
|
$166.31 B
|
$176.00 B
|
$180.80 B
|
$186.19 B
|
$185.08 B
|
$179.80 B
|
$177.00 B
|
| Weighted Average Shares Out Diluted |
$128.90 M
|
$138.66 M
|
$159.28 M
|
$166.31 M
|
$176.04 M
|
$180.83 M
|
$186.20 M
|
$185.08 M
|
$179.85 M
|
$177.03 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
